Note that the current default version of R is 3.6.1.
Loading required package: network
network: Classes for Relational Data
Version 1.15 created on 2019-04-01.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
                    Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Martina Morris, University of Washington
                    Skye Bender-deMoll, University of Washington
 For citation information, type citation("network").
 Type help("network-package") to get started.


networkDynamic: version 0.10.0, created on 2019-04-04
Copyright (c) 2019, Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Skye Bender-deMoll, University of Washington
                    with contributions from
                    Zack Almquist, University of California -- Irvine
                    David R. Hunter, Penn State University
                    Li Wang
                    Kirk Li, University of Washington
                    Steven M. Goodreau, University of Washington
                    Jeffrey Horner
                    Martina Morris, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("networkDynamic").

Loading required package: statnet.common

Attaching package: ‘statnet.common’

The following object is masked from ‘package:base’:

    order

sna: Tools for Social Network Analysis
Version 2.4 created on 2016-07-23.
copyright (c) 2005, Carter T. Butts, University of California-Irvine
 For citation information, type citation("sna").
 Type help(package="sna") to get started.


ergm: version 3.10.4, created on 2019-06-10
Copyright (c) 2019, Mark S. Handcock, University of California -- Los Angeles
                    David R. Hunter, Penn State University
                    Carter T. Butts, University of California -- Irvine
                    Steven M. Goodreau, University of Washington
                    Pavel N. Krivitsky, University of Wollongong
                    Martina Morris, University of Washington
                    with contributions from
                    Li Wang
                    Kirk Li, University of Washington
                    Skye Bender-deMoll, University of Washington
                    Chad Klumb
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("ergm").

NOTE: Versions before 3.6.1 had a bug in the implementation of the bd()
constriant which distorted the sampled distribution somewhat. In
addition, Sampson's Monks datasets had mislabeled vertices. See the
NEWS and the documentation for more details.

NOTE: Some common term arguments pertaining to vertex attribute and
level selection have changed in 3.10.0. See terms help for more
details. Use ‘options(ergm.term=list(version="3.9.4"))’ to use old
behavior.


tergm: version 3.6.1, created on 2019-06-12
Copyright (c) 2019, Pavel N. Krivitsky, University of Wollongong
                    Mark S. Handcock, University of California -- Los Angeles
                    with contributions from
                    David R. Hunter, Penn State University
                    Steven M. Goodreau, University of Washington
                    Martina Morris, University of Washington
                    Nicole Bohme Carnegie, New York University
                    Carter T. Butts, University of California -- Irvine
                    Ayn Leslie-Cook, University of Washington
                    Skye Bender-deMoll
                    Li Wang
                    Kirk Li, University of Washington
Based on "statnet" project software (statnet.org).
For license and citation information see statnet.org/attribution
or type citation("tergm").

Starting maximum pseudolikelihood estimation (MPLE):
Evaluating the predictor and response matrix.
Maximizing the pseudolikelihood.
Finished MPLE.
Starting Monte Carlo maximum likelihood estimation (MCMLE):
Iteration 1 of at most 500:
Optimizing with step length 0.309470003658123.
The log-likelihood improved by 3.11.
Iteration 2 of at most 500:
Optimizing with step length 0.550981573601301.
The log-likelihood improved by 3.522.
Iteration 3 of at most 500:
Optimizing with step length 0.912275385138678.
The log-likelihood improved by 2.867.
Iteration 4 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.1455.
Step length converged once. Increasing MCMC sample size.
Iteration 5 of at most 500:
Optimizing with step length 1.
The log-likelihood improved by 0.08236.
Step length converged twice. Stopping.
Finished MCMLE.
This model was fit using MCMC.  To examine model diagnostics and check
for degeneracy, use the mcmc.diagnostics() function.
 degree0  degree1  degree2  degree3  degree4  degree5  degree6  degree7 
       2       24     1340     1054      797      322      355      360 
 degree8  degree9 degree10 degree11 degree12 degree13 degree14 degree15 
     275      198      126       77       40       16       12        1 
degree16 
       1 
1 
disease_progression 
H-positive risk:  933 897 117 837 478 122 840 403 121 60 123 69 
H-negative risk:  897 933 840 837 403 478 122 117 123 121 69 60 
New BC onsets:  2
BC status:  4998 2 
BC subtype:  4998 2 

clinical_engagement 
diagnosis 
demography 
69 new agents 
2 
disease_progression 
H-positive risk:  936 901 119 841 472 122 838 398 118 63 122 70 
H-negative risk:  901 936 838 841 398 472 122 119 122 118 70 63 
New BC onsets:  5
BC status:  4995 5 
BC subtype:  4995 3 2 

clinical_engagement 
diagnosis 
demography 
43 new agents 
3 
disease_progression 
H-positive risk:  941 902 119 847 468 121 841 391 117 62 122 69 
H-negative risk:  902 941 841 847 391 468 121 119 122 117 69 62 
New BC onsets:  6
BC status:  4994 6 
BC subtype:  4994 4 2 

clinical_engagement 
diagnosis 
demography 
55 new agents 
4 
disease_progression 
H-positive risk:  949 904 120 849 462 124 842 384 116 61 122 67 
H-negative risk:  904 949 842 849 384 462 124 120 122 116 67 61 
New BC onsets:  7
BC status:  4993 7 
BC subtype:  4993 5 2 

clinical_engagement 
diagnosis 
demography 
71 new agents 
5 
disease_progression 
H-positive risk:  956 902 119 852 461 127 844 377 115 62 121 64 
H-negative risk:  902 956 844 852 377 461 127 119 121 115 64 62 
New BC onsets:  11
BC status:  4989 11 
BC subtype:  4989 7 4 

clinical_engagement 
diagnosis 
demography 
73 new agents 
6 
disease_progression 
H-positive risk:  968 909 116 854 450 129 840 373 118 60 121 62 
H-negative risk:  909 968 840 854 373 450 129 116 121 118 62 60 
New BC onsets:  12
BC status:  4988 12 
BC subtype:  4988 8 4 

clinical_engagement 
diagnosis 
demography 
48 new agents 
7 
disease_progression 
H-positive risk:  971 915 116 851 445 130 839 372 118 60 122 61 
H-negative risk:  915 971 839 851 372 445 130 116 122 118 61 60 
New BC onsets:  15
BC status:  4985 15 
BC subtype:  4985 10 5 

clinical_engagement 
diagnosis 
demography 
65 new agents 
8 
disease_progression 
H-positive risk:  978 915 118 851 440 134 841 367 118 60 119 59 
H-negative risk:  915 978 841 851 367 440 134 118 119 118 59 60 
New BC onsets:  17
BC status:  4983 17 
BC subtype:  4983 11 6 

clinical_engagement 
diagnosis 
demography 
56 new agents 
9 
disease_progression 
H-positive risk:  977 915 116 852 447 132 837 365 119 59 122 59 
H-negative risk:  915 977 837 852 365 447 132 116 122 119 59 59 
New BC onsets:  19
BC status:  4981 19 
BC subtype:  4981 13 6 

clinical_engagement 
diagnosis 
demography 
57 new agents 
10 
disease_progression 
H-positive risk:  984 916 112 848 446 134 835 366 118 59 122 60 
H-negative risk:  916 984 835 848 366 446 134 112 122 118 60 59 
New BC onsets:  20
BC status:  4980 20 
BC subtype:  4980 13 7 

clinical_engagement 
diagnosis 
demography 
71 new agents 
11 
disease_progression 
H-positive risk:  984 921 113 854 435 135 834 365 116 60 121 62 
H-negative risk:  921 984 834 854 365 435 135 113 121 116 62 60 
New BC onsets:  22
BC status:  4978 22 
BC subtype:  4978 15 7 

clinical_engagement 
diagnosis 
demography 
54 new agents 
12 
disease_progression 
H-positive risk:  989 921 116 855 426 134 835 364 116 61 121 62 
H-negative risk:  921 989 835 855 364 426 134 116 121 116 62 61 
New BC onsets:  23
BC status:  4977 23 
BC subtype:  4977 16 7 

clinical_engagement 
diagnosis 
demography 
59 new agents 
13 
disease_progression 
H-positive risk:  911 843 101 924 424 121 924 362 131 62 134 63 
H-negative risk:  843 911 924 924 362 424 121 101 134 131 63 62 
New BC onsets:  26
BC status:  4974 26 
BC subtype:  4974 17 9 

clinical_engagement 
diagnosis 
demography 
191 new agents 
14 
disease_progression 
H-positive risk:  945 873 108 867 427 127 868 391 132 66 127 69 
H-negative risk:  873 945 868 867 391 427 127 108 127 132 69 66 
New BC onsets:  35
BC status:  4965 35 
BC subtype:  4965 22 13 

clinical_engagement 
diagnosis 
demography 
75 new agents 
15 
disease_progression 
H-positive risk:  950 879 107 870 428 127 866 381 132 65 127 68 
H-negative risk:  879 950 866 870 381 428 127 107 127 132 68 65 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 21 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
16 
disease_progression 
H-positive risk:  952 884 109 877 430 125 868 372 129 60 128 66 
H-negative risk:  884 952 868 877 372 430 125 109 128 129 66 60 
New BC onsets:  34
BC status:  4966 34 
BC subtype:  4966 21 13 

clinical_engagement 
diagnosis 
demography 
48 new agents 
17 
disease_progression 
H-positive risk:  947 887 111 889 425 126 869 369 127 62 125 63 
H-negative risk:  887 947 869 889 369 425 126 111 125 127 63 62 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 23 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
18 
disease_progression 
H-positive risk:  953 887 114 893 412 127 870 367 126 64 126 61 
H-negative risk:  887 953 870 893 367 412 127 114 126 126 61 64 
New BC onsets:  37
BC status:  4963 37 
BC subtype:  4963 22 15 

clinical_engagement 
diagnosis 
demography 
60 new agents 
19 
disease_progression 
H-positive risk:  960 892 115 885 407 129 870 367 124 64 125 62 
H-negative risk:  892 960 870 885 367 407 129 115 125 124 62 64 
New BC onsets:  40
BC status:  4960 40 
BC subtype:  4960 25 15 

clinical_engagement 
diagnosis 
demography 
56 new agents 
20 
disease_progression 
H-positive risk:  961 896 113 879 411 129 873 361 124 65 126 62 
H-negative risk:  896 961 873 879 361 411 129 113 126 124 62 65 
New BC onsets:  42
BC status:  4958 42 
BC subtype:  4958 26 16 

clinical_engagement 
diagnosis 
demography 
61 new agents 
21 
disease_progression 
H-positive risk:  964 907 111 875 413 127 875 353 125 64 125 61 
H-negative risk:  907 964 875 875 353 413 127 111 125 125 61 64 
New BC onsets:  46
BC status:  4954 46 
BC subtype:  4954 30 16 

clinical_engagement 
diagnosis 
demography 
65 new agents 
22 
disease_progression 
H-positive risk:  969 912 113 876 404 129 873 350 130 62 124 58 
H-negative risk:  912 969 873 876 350 404 129 113 124 130 58 62 
New BC onsets:  49
BC status:  4951 49 
BC subtype:  4951 32 17 

clinical_engagement 
diagnosis 
demography 
70 new agents 
23 
disease_progression 
H-positive risk:  978 923 115 879 391 126 867 344 132 63 125 57 
H-negative risk:  923 978 867 879 344 391 126 115 125 132 57 63 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 35 18 

clinical_engagement 
diagnosis 
demography 
61 new agents 
24 
disease_progression 
H-positive risk:  982 929 115 878 391 127 864 339 129 62 125 59 
H-negative risk:  929 982 864 878 339 391 127 115 125 129 59 62 
New BC onsets:  53
BC status:  4947 53 
BC subtype:  4947 35 18 

clinical_engagement 
diagnosis 
demography 
65 new agents 
25 
disease_progression 
H-positive risk:  912 866 109 951 391 117 927 331 141 62 133 60 
H-negative risk:  866 912 927 951 331 391 117 109 133 141 60 62 
New BC onsets:  55
BC status:  4945 55 
BC subtype:  4945 37 18 

clinical_engagement 
diagnosis 
demography 
180 new agents 
26 
disease_progression 
H-positive risk:  941 888 109 922 403 118 884 354 135 53 133 60 
H-negative risk:  888 941 884 922 354 403 118 109 133 135 60 53 
New BC onsets:  57
BC status:  4943 57 
BC subtype:  4943 39 18 

clinical_engagement 
diagnosis 
demography 
69 new agents 
27 
disease_progression 
H-positive risk:  944 893 109 921 406 122 881 349 133 51 133 58 
H-negative risk:  893 944 881 921 349 406 122 109 133 133 58 51 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 41 19 

clinical_engagement 
diagnosis 
demography 
61 new agents 
28 
disease_progression 
H-positive risk:  942 892 109 923 407 124 876 350 131 51 136 59 
H-negative risk:  892 942 876 923 350 407 124 109 136 131 59 51 
New BC onsets:  60
BC status:  4940 60 
BC subtype:  4940 41 19 

clinical_engagement 
diagnosis 
demography 
56 new agents 
29 
disease_progression 
H-positive risk:  950 889 108 931 407 122 869 349 129 52 135 59 
H-negative risk:  889 950 869 931 349 407 122 108 135 129 59 52 
New BC onsets:  63
BC status:  4937 63 
BC subtype:  4937 43 20 

clinical_engagement 
diagnosis 
demography 
62 new agents 
30 
disease_progression 
H-positive risk:  948 896 108 928 410 120 868 350 127 51 136 58 
H-negative risk:  896 948 868 928 350 410 120 108 136 127 58 51 
New BC onsets:  65
BC status:  4935 65 
BC subtype:  4935 44 21 

clinical_engagement 
diagnosis 
demography 
69 new agents 
31 
disease_progression 
H-positive risk:  951 902 110 923 401 118 872 351 125 50 136 61 
H-negative risk:  902 951 872 923 351 401 118 110 136 125 61 50 
New BC onsets:  67
BC status:  4933 67 
BC subtype:  4933 48 19 

clinical_engagement 
diagnosis 
demography 
54 new agents 
32 
disease_progression 
H-positive risk:  961 907 110 922 396 118 865 348 124 51 136 62 
H-negative risk:  907 961 865 922 348 396 118 110 136 124 62 51 
New BC onsets:  71
BC status:  4929 71 
BC subtype:  4929 51 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
33 
disease_progression 
H-positive risk:  958 909 111 925 395 119 864 349 124 50 136 60 
H-negative risk:  909 958 864 925 349 395 119 111 136 124 60 50 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 52 22 

clinical_engagement 
diagnosis 
demography 
58 new agents 
34 
disease_progression 
H-positive risk:  959 909 111 924 396 119 869 346 122 50 134 61 
H-negative risk:  909 959 869 924 346 396 119 111 134 122 61 50 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 53 22 

clinical_engagement 
diagnosis 
demography 
47 new agents 
35 
disease_progression 
H-positive risk:  961 917 109 926 394 119 866 343 120 51 132 62 
H-negative risk:  917 961 866 926 343 394 119 109 132 120 62 51 
New BC onsets:  74
BC status:  4926 74 
BC subtype:  4926 53 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
36 
disease_progression 
H-positive risk:  960 923 112 922 394 121 866 340 121 50 130 61 
H-negative risk:  923 960 866 922 340 394 121 112 130 121 61 50 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 53 22 

clinical_engagement 
diagnosis 
demography 
52 new agents 
37 
disease_progression 
H-positive risk:  887 851 103 1002 390 114 942 339 129 47 138 58 
H-negative risk:  851 887 942 1002 339 390 114 103 138 129 58 47 
New BC onsets:  75
BC status:  4925 75 
BC subtype:  4925 53 22 

clinical_engagement 
diagnosis 
demography 
158 new agents 
38 
disease_progression 
H-positive risk:  905 871 106 971 396 115 919 361 122 43 136 55 
H-negative risk:  871 905 919 971 361 396 115 106 136 122 55 43 
New BC onsets:  79
BC status:  4921 79 
BC subtype:  4921 52 27 

clinical_engagement 
diagnosis 
demography 
78 new agents 
39 
disease_progression 
H-positive risk:  906 869 105 959 403 116 923 366 121 44 134 54 
H-negative risk:  869 906 923 959 366 403 116 105 134 121 54 44 
New BC onsets:  80
BC status:  4920 80 
BC subtype:  4920 54 26 

clinical_engagement 
diagnosis 
demography 
64 new agents 
40 
disease_progression 
H-positive risk:  905 880 105 950 401 115 927 364 122 45 135 51 
H-negative risk:  880 905 927 950 364 401 115 105 135 122 51 45 
New BC onsets:  83
BC status:  4917 83 
BC subtype:  4917 56 27 

clinical_engagement 
diagnosis 
demography 
61 new agents 
41 
disease_progression 
H-positive risk:  911 884 107 945 398 115 920 364 123 46 134 53 
H-negative risk:  884 911 920 945 364 398 115 107 134 123 53 46 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 57 29 

clinical_engagement 
diagnosis 
demography 
60 new agents 
42 
disease_progression 
H-positive risk:  916 884 106 941 390 117 924 358 125 48 135 56 
H-negative risk:  884 916 924 941 358 390 117 106 135 125 56 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 56 28 

clinical_engagement 
diagnosis 
demography 
62 new agents 
43 
disease_progression 
H-positive risk:  922 885 106 943 388 115 923 353 125 47 137 56 
H-negative risk:  885 922 923 943 353 388 115 106 137 125 56 47 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 57 28 

clinical_engagement 
diagnosis 
demography 
60 new agents 
44 
disease_progression 
H-positive risk:  924 887 103 938 385 115 931 355 123 48 138 53 
H-negative risk:  887 924 931 938 355 385 115 103 138 123 53 48 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 57 28 

clinical_engagement 
diagnosis 
demography 
60 new agents 
45 
disease_progression 
H-positive risk:  932 885 101 941 384 120 923 349 125 48 138 54 
H-negative risk:  885 932 923 941 349 384 120 101 138 125 54 48 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 57 27 

clinical_engagement 
diagnosis 
demography 
77 new agents 
46 
disease_progression 
H-positive risk:  933 885 102 946 379 121 930 350 121 47 131 55 
H-negative risk:  885 933 930 946 350 379 121 102 131 121 55 47 
New BC onsets:  81
BC status:  4919 81 
BC subtype:  4919 55 26 

clinical_engagement 
diagnosis 
demography 
51 new agents 
47 
disease_progression 
H-positive risk:  938 885 103 934 384 120 928 353 122 45 132 56 
H-negative risk:  885 938 928 934 353 384 120 103 132 122 56 45 
New BC onsets:  82
BC status:  4918 82 
BC subtype:  4918 56 26 

clinical_engagement 
diagnosis 
demography 
61 new agents 
48 
disease_progression 
H-positive risk:  945 873 104 939 388 119 924 352 124 44 132 56 
H-negative risk:  873 945 924 939 352 388 119 104 132 124 56 44 
New BC onsets:  84
BC status:  4916 84 
BC subtype:  4916 57 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
49 
disease_progression 
H-positive risk:  889 831 98 986 388 112 980 354 128 44 137 53 
H-negative risk:  831 889 980 986 354 388 112 98 137 128 53 44 
New BC onsets:  86
BC status:  4914 86 
BC subtype:  4914 59 27 

clinical_engagement 
diagnosis 
demography 
153 new agents 
50 
disease_progression 
H-positive risk:  902 847 99 952 400 113 971 360 125 42 129 60 
H-negative risk:  847 902 971 952 360 400 113 99 129 125 60 42 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 62 25 

clinical_engagement 
diagnosis 
demography 
63 new agents 
51 
disease_progression 
H-positive risk:  899 859 101 940 397 116 969 367 124 41 128 59 
H-negative risk:  859 899 969 940 367 397 116 101 128 124 59 41 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 65 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
52 
disease_progression 
H-positive risk:  900 861 103 939 401 114 969 360 123 41 128 61 
H-negative risk:  861 900 969 939 360 401 114 103 128 123 61 41 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 67 25 

clinical_engagement 
diagnosis 
demography 
52 new agents 
53 
disease_progression 
H-positive risk:  903 856 102 943 399 114 967 364 120 42 129 61 
H-negative risk:  856 903 967 943 364 399 114 102 129 120 61 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 68 27 

clinical_engagement 
diagnosis 
demography 
55 new agents 
54 
disease_progression 
H-positive risk:  901 857 102 939 402 114 967 364 121 44 129 60 
H-negative risk:  857 901 967 939 364 402 114 102 129 121 60 44 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
55 
disease_progression 
H-positive risk:  896 856 105 941 408 115 965 363 123 41 124 63 
H-negative risk:  856 896 965 941 363 408 115 105 124 123 63 41 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
56 
disease_progression 
H-positive risk:  897 865 108 936 407 115 964 358 123 42 123 62 
H-negative risk:  865 897 964 936 358 407 115 108 123 123 62 42 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
66 new agents 
57 
disease_progression 
H-positive risk:  892 870 109 936 406 114 967 355 125 41 124 61 
H-negative risk:  870 892 967 936 355 406 114 109 124 125 61 41 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 66 27 

clinical_engagement 
diagnosis 
demography 
69 new agents 
58 
disease_progression 
H-positive risk:  899 873 109 931 402 113 967 355 124 43 125 59 
H-negative risk:  873 899 967 931 355 402 113 109 125 124 59 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 65 29 

clinical_engagement 
diagnosis 
demography 
76 new agents 
59 
disease_progression 
H-positive risk:  900 882 108 931 396 112 961 356 125 42 126 61 
H-negative risk:  882 900 961 931 356 396 112 108 126 125 61 42 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 64 28 

clinical_engagement 
diagnosis 
demography 
59 new agents 
60 
disease_progression 
H-positive risk:  901 879 108 933 392 110 969 352 125 43 127 61 
H-negative risk:  879 901 969 933 352 392 110 108 127 125 61 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
67 new agents 
61 
disease_progression 
H-positive risk:  827 814 106 1000 387 106 1044 352 129 43 131 61 
H-negative risk:  814 827 1044 1000 352 387 106 106 131 129 61 43 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 66 28 

clinical_engagement 
diagnosis 
demography 
113 new agents 
62 
disease_progression 
H-positive risk:  830 821 107 972 403 107 1025 370 125 48 132 60 
H-negative risk:  821 830 1025 972 370 403 107 107 132 125 60 48 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 64 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
63 
disease_progression 
H-positive risk:  831 827 106 968 400 107 1022 372 123 49 133 62 
H-negative risk:  827 831 1022 968 372 400 107 106 133 123 62 49 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 65 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
64 
disease_progression 
H-positive risk:  836 833 107 963 395 107 1026 372 120 48 132 61 
H-negative risk:  833 836 1026 963 372 395 107 107 132 120 61 48 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
65 
disease_progression 
H-positive risk:  836 837 109 957 391 110 1022 376 124 47 132 59 
H-negative risk:  837 836 1022 957 376 391 110 109 132 124 59 47 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 67 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
66 
disease_progression 
H-positive risk:  835 829 110 965 384 110 1026 374 126 46 134 61 
H-negative risk:  829 835 1026 965 374 384 110 110 134 126 61 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 67 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
67 
disease_progression 
H-positive risk:  838 829 110 972 381 112 1016 374 128 44 136 60 
H-negative risk:  829 838 1016 972 374 381 112 110 136 128 60 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 66 23 

clinical_engagement 
diagnosis 
demography 
65 new agents 
68 
disease_progression 
H-positive risk:  837 827 112 969 376 114 1026 371 126 45 135 62 
H-negative risk:  827 837 1026 969 371 376 114 112 135 126 62 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
71 new agents 
69 
disease_progression 
H-positive risk:  839 828 111 966 374 113 1023 376 129 43 134 64 
H-negative risk:  828 839 1023 966 376 374 113 111 134 129 64 43 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
67 new agents 
70 
disease_progression 
H-positive risk:  834 824 113 972 375 115 1024 370 129 47 131 66 
H-negative risk:  824 834 1024 972 370 375 115 113 131 129 66 47 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 70 24 

clinical_engagement 
diagnosis 
demography 
79 new agents 
71 
disease_progression 
H-positive risk:  833 821 115 973 379 118 1020 371 127 47 130 66 
H-negative risk:  821 833 1020 973 371 379 118 115 130 127 66 47 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
72 
disease_progression 
H-positive risk:  837 827 115 970 376 116 1015 368 130 46 135 65 
H-negative risk:  827 837 1015 970 368 376 116 115 135 130 65 46 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
73 
disease_progression 
H-positive risk:  783 778 108 1025 372 105 1064 371 142 46 143 63 
H-negative risk:  778 783 1064 1025 371 372 105 108 143 142 63 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 70 23 

clinical_engagement 
diagnosis 
demography 
116 new agents 
74 
disease_progression 
H-positive risk:  788 782 107 997 383 106 1055 387 139 50 139 67 
H-negative risk:  782 788 1055 997 387 383 106 107 139 139 67 50 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
75 
disease_progression 
H-positive risk:  796 788 109 992 374 101 1044 397 141 50 139 69 
H-negative risk:  788 796 1044 992 397 374 101 109 139 141 69 50 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 69 25 

clinical_engagement 
diagnosis 
demography 
65 new agents 
76 
disease_progression 
H-positive risk:  796 791 107 995 367 103 1045 393 142 49 140 72 
H-negative risk:  791 796 1045 995 393 367 103 107 140 142 72 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
56 new agents 
77 
disease_progression 
H-positive risk:  799 796 108 990 373 103 1041 391 143 46 141 69 
H-negative risk:  796 799 1041 990 391 373 103 108 141 143 69 46 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
68 new agents 
78 
disease_progression 
H-positive risk:  801 797 109 992 375 105 1037 385 142 46 144 67 
H-negative risk:  797 801 1037 992 385 375 105 109 144 142 67 46 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 71 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
79 
disease_progression 
H-positive risk:  797 794 113 1003 368 105 1040 381 143 45 143 68 
H-negative risk:  794 797 1040 1003 381 368 105 113 143 143 68 45 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
59 new agents 
80 
disease_progression 
H-positive risk:  796 794 114 1004 373 106 1037 379 145 45 140 67 
H-negative risk:  794 796 1037 1004 379 373 106 114 140 145 67 45 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
81 
disease_progression 
H-positive risk:  795 794 116 1008 379 108 1025 382 144 45 136 68 
H-negative risk:  794 795 1025 1008 382 379 108 116 136 144 68 45 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 69 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
82 
disease_progression 
H-positive risk:  799 793 119 1008 373 110 1021 386 146 46 133 66 
H-negative risk:  793 799 1021 1008 386 373 110 119 133 146 66 46 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 71 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
83 
disease_progression 
H-positive risk:  808 801 117 1006 359 111 1017 390 147 44 136 64 
H-negative risk:  801 808 1017 1006 390 359 111 117 136 147 64 44 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 68 21 

clinical_engagement 
diagnosis 
demography 
60 new agents 
84 
disease_progression 
H-positive risk:  806 807 121 1004 362 109 1015 387 145 47 135 62 
H-negative risk:  807 806 1015 1004 387 362 109 121 135 145 62 47 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 70 22 

clinical_engagement 
diagnosis 
demography 
62 new agents 
85 
disease_progression 
H-positive risk:  759 764 116 1051 362 108 1063 386 145 46 143 57 
H-negative risk:  764 759 1063 1051 386 362 108 116 143 145 57 46 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 72 22 

clinical_engagement 
diagnosis 
demography 
93 new agents 
86 
disease_progression 
H-positive risk:  750 760 115 1044 367 111 1064 396 140 50 143 60 
H-negative risk:  760 750 1064 1044 396 367 111 115 143 140 60 50 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 74 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
87 
disease_progression 
H-positive risk:  754 757 119 1036 373 112 1061 395 138 53 142 60 
H-negative risk:  757 754 1061 1036 395 373 112 119 142 138 60 53 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 78 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
88 
disease_progression 
H-positive risk:  755 757 120 1027 382 114 1058 395 140 54 142 56 
H-negative risk:  757 755 1058 1027 395 382 114 120 142 140 56 54 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
68 new agents 
89 
disease_progression 
H-positive risk:  757 766 120 1018 378 112 1060 391 144 56 139 59 
H-negative risk:  766 757 1060 1018 391 378 112 120 139 144 59 56 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
90 
disease_progression 
H-positive risk:  758 774 122 1016 377 113 1063 387 143 55 135 57 
H-negative risk:  774 758 1063 1016 387 377 113 122 135 143 57 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
64 new agents 
91 
disease_progression 
H-positive risk:  762 776 122 1015 375 111 1064 386 142 55 132 60 
H-negative risk:  776 762 1064 1015 386 375 111 122 132 142 60 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
55 new agents 
92 
disease_progression 
H-positive risk:  762 775 124 1011 376 112 1068 384 140 56 134 58 
H-negative risk:  775 762 1068 1011 384 376 112 124 134 140 58 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
63 new agents 
93 
disease_progression 
H-positive risk:  759 777 126 1010 374 112 1065 387 143 56 134 57 
H-negative risk:  777 759 1065 1010 387 374 112 126 134 143 57 56 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
94 
disease_progression 
H-positive risk:  756 781 124 1017 375 114 1069 376 143 55 132 58 
H-negative risk:  781 756 1069 1017 376 375 114 124 132 143 58 55 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 85 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
95 
disease_progression 
H-positive risk:  757 774 126 1017 373 115 1070 379 142 55 135 57 
H-negative risk:  774 757 1070 1017 379 373 115 126 135 142 57 55 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
96 
disease_progression 
H-positive risk:  764 777 124 1019 379 114 1061 367 146 53 139 57 
H-negative risk:  777 764 1061 1019 367 379 114 124 139 146 57 53 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 89 23 

clinical_engagement 
diagnosis 
demography 
63 new agents 
97 
disease_progression 
H-positive risk:  717 727 117 1080 376 102 1095 375 157 52 144 58 
H-negative risk:  727 717 1095 1080 375 376 102 117 144 157 58 52 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 87 24 

clinical_engagement 
diagnosis 
demography 
95 new agents 
98 
disease_progression 
H-positive risk:  722 727 116 1065 389 107 1069 386 163 53 142 61 
H-negative risk:  727 722 1069 1065 386 389 107 116 142 163 61 53 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
110 new agents 
99 
disease_progression 
H-positive risk:  730 735 119 1067 368 103 1072 387 168 50 143 58 
H-negative risk:  735 730 1072 1067 387 368 103 119 143 168 58 50 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
59 new agents 
100 
disease_progression 
H-positive risk:  723 727 116 1075 372 103 1081 384 168 50 142 59 
H-negative risk:  727 723 1081 1075 384 372 103 116 142 168 59 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
71 new agents 
101 
disease_progression 
H-positive risk:  734 719 115 1077 364 102 1086 384 166 49 146 58 
H-negative risk:  719 734 1086 1077 384 364 102 115 146 166 58 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
54 new agents 
102 
disease_progression 
H-positive risk:  732 716 115 1078 361 102 1095 383 164 48 147 59 
H-negative risk:  716 732 1095 1078 383 361 102 115 147 164 59 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
81 new agents 
103 
disease_progression 
H-positive risk:  730 718 118 1084 360 101 1094 374 168 46 150 57 
H-negative risk:  718 730 1094 1084 374 360 101 118 150 168 57 46 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
73 new agents 
104 
disease_progression 
H-positive risk:  734 711 119 1092 367 102 1081 376 167 45 150 56 
H-negative risk:  711 734 1081 1092 376 367 102 119 150 167 56 45 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
105 
disease_progression 
H-positive risk:  733 713 116 1099 366 100 1082 369 165 48 152 57 
H-negative risk:  713 733 1082 1099 369 366 100 116 152 165 57 48 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
106 
disease_progression 
H-positive risk:  745 709 115 1093 362 102 1088 370 163 48 148 57 
H-negative risk:  709 745 1088 1093 370 362 102 115 148 163 57 48 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
107 
disease_progression 
H-positive risk:  743 708 117 1082 363 101 1094 380 162 48 145 57 
H-negative risk:  708 743 1094 1082 380 363 101 117 145 162 57 48 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 84 20 

clinical_engagement 
diagnosis 
demography 
79 new agents 
108 
disease_progression 
H-positive risk:  741 715 117 1084 363 102 1097 377 158 48 143 55 
H-negative risk:  715 741 1097 1084 377 363 102 117 143 158 55 48 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 83 19 

clinical_engagement 
diagnosis 
demography 
69 new agents 
109 
disease_progression 
H-positive risk:  694 686 111 1112 367 100 1142 374 160 49 150 55 
H-negative risk:  686 694 1142 1112 374 367 100 111 150 160 55 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
110 
disease_progression 
H-positive risk:  688 679 113 1106 386 96 1138 381 159 50 150 54 
H-negative risk:  679 688 1138 1106 381 386 96 113 150 159 54 50 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
111 
disease_progression 
H-positive risk:  691 684 113 1112 388 98 1126 380 158 50 146 54 
H-negative risk:  684 691 1126 1112 380 388 98 113 146 158 54 50 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
112 
disease_progression 
H-positive risk:  684 690 114 1116 393 98 1117 381 157 51 146 53 
H-negative risk:  690 684 1117 1116 381 393 98 114 146 157 53 51 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
74 new agents 
113 
disease_progression 
H-positive risk:  688 691 111 1120 386 97 1119 383 154 51 147 53 
H-negative risk:  691 688 1119 1120 383 386 97 111 147 154 53 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
114 
disease_progression 
H-positive risk:  687 692 111 1116 385 94 1123 384 152 54 150 52 
H-negative risk:  692 687 1123 1116 384 385 94 111 150 152 52 54 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 82 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
115 
disease_progression 
H-positive risk:  687 692 111 1106 392 94 1122 386 150 58 152 50 
H-negative risk:  692 687 1122 1106 386 392 94 111 152 150 50 58 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 83 24 

clinical_engagement 
diagnosis 
demography 
64 new agents 
116 
disease_progression 
H-positive risk:  684 696 109 1103 391 94 1133 379 146 64 152 49 
H-negative risk:  696 684 1133 1103 379 391 94 109 152 146 49 64 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
75 new agents 
117 
disease_progression 
H-positive risk:  689 693 109 1104 392 91 1128 382 143 64 154 51 
H-negative risk:  693 689 1128 1104 382 392 91 109 154 143 51 64 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
59 new agents 
118 
disease_progression 
H-positive risk:  685 690 108 1100 397 90 1126 385 147 65 155 52 
H-negative risk:  690 685 1126 1100 385 397 90 108 155 147 52 65 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 86 24 

clinical_engagement 
diagnosis 
demography 
77 new agents 
119 
disease_progression 
H-positive risk:  683 699 105 1096 396 87 1123 389 151 65 155 51 
H-negative risk:  699 683 1123 1096 389 396 87 105 155 151 51 65 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 85 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
120 
disease_progression 
H-positive risk:  685 691 105 1094 393 87 1133 388 152 65 158 49 
H-negative risk:  691 685 1133 1094 388 393 87 105 158 152 49 65 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 86 22 

clinical_engagement 
diagnosis 
demography 
80 new agents 
121 
disease_progression 
H-positive risk:  645 646 99 1138 399 80 1175 382 157 63 167 49 
H-negative risk:  646 645 1175 1138 382 399 80 99 167 157 49 63 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 85 22 

clinical_engagement 
diagnosis 
demography 
96 new agents 
122 
disease_progression 
H-positive risk:  639 649 100 1138 401 79 1174 393 158 56 163 50 
H-negative risk:  649 639 1174 1138 393 401 79 100 163 158 50 56 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 84 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
123 
disease_progression 
H-positive risk:  647 647 101 1135 403 80 1166 398 160 55 159 49 
H-negative risk:  647 647 1166 1135 398 403 80 101 159 160 49 55 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
76 new agents 
124 
disease_progression 
H-positive risk:  656 648 103 1130 402 81 1163 395 158 55 160 49 
H-negative risk:  648 656 1163 1130 395 402 81 103 160 158 49 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 82 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
125 
disease_progression 
H-positive risk:  645 658 102 1122 408 83 1161 401 158 54 159 49 
H-negative risk:  658 645 1161 1122 401 408 83 102 159 158 49 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 83 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
126 
disease_progression 
H-positive risk:  637 667 104 1119 400 84 1168 397 161 53 162 48 
H-negative risk:  667 637 1168 1119 397 400 84 104 162 161 48 53 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
127 
disease_progression 
H-positive risk:  640 663 101 1118 412 85 1156 402 158 52 166 47 
H-negative risk:  663 640 1156 1118 402 412 85 101 166 158 47 52 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 81 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
128 
disease_progression 
H-positive risk:  637 674 104 1107 418 87 1149 400 160 52 167 45 
H-negative risk:  674 637 1149 1107 400 418 87 104 167 160 45 52 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 84 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
129 
disease_progression 
H-positive risk:  632 672 103 1103 429 85 1149 405 158 54 168 42 
H-negative risk:  672 632 1149 1103 405 429 85 103 168 158 42 54 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 88 19 

clinical_engagement 
diagnosis 
demography 
73 new agents 
130 
disease_progression 
H-positive risk:  640 676 105 1102 419 83 1152 406 155 54 168 40 
H-negative risk:  676 640 1152 1102 406 419 83 105 168 155 40 54 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
131 
disease_progression 
H-positive risk:  633 679 105 1108 413 87 1159 401 150 58 168 39 
H-negative risk:  679 633 1159 1108 401 413 87 105 168 150 39 58 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 90 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
132 
disease_progression 
H-positive risk:  635 681 106 1107 408 89 1161 399 145 62 166 41 
H-negative risk:  681 635 1161 1107 399 408 89 106 166 145 41 62 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 92 18 

clinical_engagement 
diagnosis 
demography 
63 new agents 
133 
disease_progression 
H-positive risk:  634 682 104 1108 410 92 1157 401 144 63 165 40 
H-negative risk:  682 634 1157 1108 401 410 92 104 165 144 40 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 93 18 

clinical_engagement 
diagnosis 
demography 
101 new agents 
134 
disease_progression 
H-positive risk:  638 685 106 1101 407 91 1145 417 142 65 161 42 
H-negative risk:  685 638 1145 1101 417 407 91 106 161 142 42 65 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 89 17 

clinical_engagement 
diagnosis 
demography 
85 new agents 
135 
disease_progression 
H-positive risk:  637 688 102 1099 410 91 1146 423 140 64 161 39 
H-negative risk:  688 637 1146 1099 423 410 91 102 161 140 39 64 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 84 18 

clinical_engagement 
diagnosis 
demography 
67 new agents 
136 
disease_progression 
H-positive risk:  637 689 103 1103 405 93 1144 422 140 64 163 37 
H-negative risk:  689 637 1144 1103 422 405 93 103 163 140 37 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
137 
disease_progression 
H-positive risk:  640 695 102 1091 405 94 1148 420 141 65 162 37 
H-negative risk:  695 640 1148 1091 420 405 94 102 162 141 37 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 83 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
138 
disease_progression 
H-positive risk:  639 696 103 1097 401 90 1148 418 140 65 165 38 
H-negative risk:  696 639 1148 1097 418 401 90 103 165 140 38 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
139 
disease_progression 
H-positive risk:  639 697 102 1088 402 88 1148 424 140 66 166 40 
H-negative risk:  697 639 1148 1088 424 402 88 102 166 140 40 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
66 new agents 
140 
disease_progression 
H-positive risk:  649 692 100 1093 403 86 1146 422 141 64 164 40 
H-negative risk:  692 649 1146 1093 422 403 86 100 164 141 40 64 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
141 
disease_progression 
H-positive risk:  651 698 99 1095 404 88 1143 415 140 65 165 37 
H-negative risk:  698 651 1143 1095 415 404 88 99 165 140 37 65 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 87 18 

clinical_engagement 
diagnosis 
demography 
72 new agents 
142 
disease_progression 
H-positive risk:  646 694 98 1103 398 84 1152 420 139 66 168 32 
H-negative risk:  694 646 1152 1103 420 398 84 98 168 139 32 66 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 89 18 

clinical_engagement 
diagnosis 
demography 
71 new agents 
143 
disease_progression 
H-positive risk:  642 693 98 1119 394 82 1146 417 140 67 170 32 
H-negative risk:  693 642 1146 1119 417 394 82 98 170 140 32 67 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 92 17 

clinical_engagement 
diagnosis 
demography 
69 new agents 
144 
disease_progression 
H-positive risk:  634 688 99 1118 391 82 1158 421 138 68 170 33 
H-negative risk:  688 634 1158 1118 421 391 82 99 170 138 33 68 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 89 19 

clinical_engagement 
diagnosis 
demography 
68 new agents 
145 
disease_progression 
H-positive risk:  638 678 97 1121 397 83 1157 419 137 68 171 34 
H-negative risk:  678 638 1157 1121 419 397 83 97 171 137 34 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
94 new agents 
146 
disease_progression 
H-positive risk:  637 680 94 1106 411 83 1145 428 139 68 172 37 
H-negative risk:  680 637 1145 1106 428 411 83 94 172 139 37 68 
New BC onsets:  110
BC status:  4890 110 
BC subtype:  4890 89 21 

clinical_engagement 
diagnosis 
demography 
70 new agents 
147 
disease_progression 
H-positive risk:  643 671 94 1121 413 84 1135 425 136 67 172 39 
H-negative risk:  671 643 1135 1121 425 413 84 94 172 136 39 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 91 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
148 
disease_progression 
H-positive risk:  647 676 93 1113 409 82 1143 427 132 68 170 40 
H-negative risk:  676 647 1143 1113 427 409 82 93 170 132 40 68 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 89 22 

clinical_engagement 
diagnosis 
demography 
66 new agents 
149 
disease_progression 
H-positive risk:  648 681 90 1115 403 85 1141 431 131 67 168 40 
H-negative risk:  681 648 1141 1115 431 403 85 90 168 131 40 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
73 new agents 
150 
disease_progression 
H-positive risk:  655 676 91 1118 400 86 1140 431 130 66 168 39 
H-negative risk:  676 655 1140 1118 431 400 86 91 168 130 39 66 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 93 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
151 
disease_progression 
H-positive risk:  655 664 88 1122 409 84 1141 434 126 65 172 40 
H-negative risk:  664 655 1141 1122 434 409 84 88 172 126 40 65 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 97 22 

clinical_engagement 
diagnosis 
demography 
79 new agents 
152 
disease_progression 
H-positive risk:  654 662 87 1129 396 83 1150 430 127 67 172 43 
H-negative risk:  662 654 1150 1129 430 396 83 87 172 127 43 67 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
74 new agents 
153 
disease_progression 
H-positive risk:  650 662 88 1133 391 82 1160 425 129 66 171 43 
H-negative risk:  662 650 1160 1133 425 391 82 88 171 129 43 66 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 96 21 

clinical_engagement 
diagnosis 
demography 
72 new agents 
154 
disease_progression 
H-positive risk:  647 666 87 1136 387 84 1160 423 128 67 170 45 
H-negative risk:  666 647 1160 1136 423 387 84 87 170 128 45 67 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 95 19 

clinical_engagement 
diagnosis 
demography 
65 new agents 
155 
disease_progression 
H-positive risk:  645 669 87 1139 386 84 1159 424 126 68 168 45 
H-negative risk:  669 645 1159 1139 424 386 84 87 168 126 45 68 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 97 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
156 
disease_progression 
H-positive risk:  646 673 83 1132 385 84 1159 428 123 69 171 47 
H-negative risk:  673 646 1159 1132 428 385 84 83 171 123 47 69 
New BC onsets:  115
BC status:  4885 115 
BC subtype:  4885 96 19 

clinical_engagement 
diagnosis 
demography 
85 new agents 
157 
disease_progression 
H-positive risk:  654 676 85 1126 380 82 1157 422 131 68 173 46 
H-negative risk:  676 654 1157 1126 422 380 82 85 173 131 46 68 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 99 18 

clinical_engagement 
diagnosis 
demography 
93 new agents 
158 
disease_progression 
H-positive risk:  661 662 88 1118 395 84 1147 430 130 70 169 46 
H-negative risk:  662 661 1147 1118 430 395 84 88 169 130 46 70 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 100 16 

clinical_engagement 
diagnosis 
demography 
70 new agents 
159 
disease_progression 
H-positive risk:  667 662 88 1111 405 85 1143 427 129 69 168 46 
H-negative risk:  662 667 1143 1111 427 405 85 88 168 129 46 69 
New BC onsets:  117
BC status:  4883 117 
BC subtype:  4883 100 17 

clinical_engagement 
diagnosis 
demography 
62 new agents 
160 
disease_progression 
H-positive risk:  662 660 89 1119 398 87 1140 430 130 72 166 47 
H-negative risk:  660 662 1140 1119 430 398 87 89 166 130 47 72 
New BC onsets:  119
BC status:  4881 119 
BC subtype:  4881 101 18 

clinical_engagement 
diagnosis 
demography 
68 new agents 
161 
disease_progression 
H-positive risk:  664 658 93 1121 405 87 1131 428 128 72 166 47 
H-negative risk:  658 664 1131 1121 428 405 87 93 166 128 47 72 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 100 18 

clinical_engagement 
diagnosis 
demography 
73 new agents 
162 
disease_progression 
H-positive risk:  667 663 88 1122 397 86 1136 421 128 73 169 50 
H-negative risk:  663 667 1136 1122 421 397 86 88 169 128 50 73 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
163 
disease_progression 
H-positive risk:  669 670 87 1116 397 88 1138 414 127 71 173 50 
H-negative risk:  670 669 1138 1116 414 397 88 87 173 127 50 71 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 104 16 

clinical_engagement 
diagnosis 
demography 
83 new agents 
164 
disease_progression 
H-positive risk:  667 669 86 1109 400 89 1139 417 126 72 175 51 
H-negative risk:  669 667 1139 1109 417 400 89 86 175 126 51 72 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 103 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
165 
disease_progression 
H-positive risk:  664 671 83 1114 402 89 1138 416 127 66 180 50 
H-negative risk:  671 664 1138 1114 416 402 89 83 180 127 50 66 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
74 new agents 
166 
disease_progression 
H-positive risk:  666 668 81 1102 402 92 1146 418 128 68 179 50 
H-negative risk:  668 666 1146 1102 418 402 92 81 179 128 50 68 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 102 18 

clinical_engagement 
diagnosis 
demography 
93 new agents 
167 
disease_progression 
H-positive risk:  669 671 85 1104 405 91 1138 415 128 65 181 48 
H-negative risk:  671 669 1138 1104 415 405 91 85 181 128 48 65 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
48 new agents 
168 
disease_progression 
H-positive risk:  673 673 87 1102 408 89 1133 411 127 69 181 47 
H-negative risk:  673 673 1133 1102 411 408 89 87 181 127 47 69 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
80 new agents 
169 
disease_progression 
H-positive risk:  675 677 85 1098 401 88 1133 412 125 71 186 49 
H-negative risk:  677 675 1133 1098 412 401 88 85 186 125 49 71 
New BC onsets:  116
BC status:  4884 116 
BC subtype:  4884 95 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
170 
disease_progression 
H-positive risk:  668 672 84 1094 418 90 1118 422 123 73 185 53 
H-negative risk:  672 668 1118 1094 422 418 90 84 185 123 53 73 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 97 21 

clinical_engagement 
diagnosis 
demography 
58 new agents 
171 
disease_progression 
H-positive risk:  656 679 84 1085 420 87 1124 427 122 72 186 58 
H-negative risk:  679 656 1124 1085 427 420 87 84 186 122 58 72 
New BC onsets:  118
BC status:  4882 118 
BC subtype:  4882 98 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
172 
disease_progression 
H-positive risk:  653 682 83 1090 417 86 1130 416 124 74 188 57 
H-negative risk:  682 653 1130 1090 416 417 86 83 188 124 57 74 
New BC onsets:  120
BC status:  4880 120 
BC subtype:  4880 99 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
173 
disease_progression 
H-positive risk:  652 685 80 1092 412 90 1129 416 123 73 190 58 
H-negative risk:  685 652 1129 1092 416 412 90 80 190 123 58 73 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 93 21 

clinical_engagement 
diagnosis 
demography 
86 new agents 
174 
disease_progression 
H-positive risk:  656 688 78 1095 401 94 1137 414 123 69 189 56 
H-negative risk:  688 656 1137 1095 414 401 94 78 189 123 56 69 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 92 21 

clinical_engagement 
diagnosis 
demography 
76 new agents 
175 
disease_progression 
H-positive risk:  660 693 80 1092 403 95 1129 415 123 67 189 54 
H-negative risk:  693 660 1129 1092 415 403 95 80 189 123 54 67 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
176 
disease_progression 
H-positive risk:  653 692 80 1097 400 97 1133 420 123 63 187 55 
H-negative risk:  692 653 1133 1097 420 400 97 80 187 123 55 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 94 19 

clinical_engagement 
diagnosis 
demography 
78 new agents 
177 
disease_progression 
H-positive risk:  654 693 80 1105 405 98 1129 413 119 63 186 55 
H-negative risk:  693 654 1129 1105 413 405 98 80 186 119 55 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 91 18 

clinical_engagement 
diagnosis 
demography 
78 new agents 
178 
disease_progression 
H-positive risk:  658 691 81 1109 402 95 1133 410 123 63 177 58 
H-negative risk:  691 658 1133 1109 410 402 95 81 177 123 58 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 90 21 

clinical_engagement 
diagnosis 
demography 
64 new agents 
179 
disease_progression 
H-positive risk:  660 687 82 1109 412 95 1128 409 120 63 178 57 
H-negative risk:  687 660 1128 1109 409 412 95 82 178 120 57 63 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 91 21 

clinical_engagement 
diagnosis 
demography 
78 new agents 
180 
disease_progression 
H-positive risk:  662 693 86 1105 416 94 1127 403 123 60 174 57 
H-negative risk:  693 662 1127 1105 403 416 94 86 174 123 57 60 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
68 new agents 
181 
disease_progression 
H-positive risk:  659 687 89 1111 423 94 1129 396 119 63 171 59 
H-negative risk:  687 659 1129 1111 396 423 94 89 171 119 59 63 
New BC onsets:  111
BC status:  4889 111 
BC subtype:  4889 91 20 

clinical_engagement 
diagnosis 
demography 
91 new agents 
182 
disease_progression 
H-positive risk:  659 695 90 1094 430 96 1130 396 116 67 169 58 
H-negative risk:  695 659 1130 1094 396 430 96 90 169 116 58 67 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
89 new agents 
183 
disease_progression 
H-positive risk:  655 699 95 1103 426 95 1123 400 115 66 162 61 
H-negative risk:  699 655 1123 1103 400 426 95 95 162 115 61 66 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 86 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
184 
disease_progression 
H-positive risk:  662 694 97 1090 434 94 1128 398 118 63 158 64 
H-negative risk:  694 662 1128 1090 398 434 94 97 158 118 64 63 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 89 20 

clinical_engagement 
diagnosis 
demography 
76 new agents 
185 
disease_progression 
H-positive risk:  670 691 97 1093 435 93 1132 391 118 62 153 65 
H-negative risk:  691 670 1132 1093 391 435 93 97 153 118 65 62 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 88 20 

clinical_engagement 
diagnosis 
demography 
77 new agents 
186 
disease_progression 
H-positive risk:  669 691 96 1102 432 92 1127 393 121 62 149 66 
H-negative risk:  691 669 1127 1102 393 432 92 96 149 121 66 62 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
71 new agents 
187 
disease_progression 
H-positive risk:  667 690 95 1100 435 92 1134 386 125 63 150 63 
H-negative risk:  690 667 1134 1100 386 435 92 95 150 125 63 63 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
76 new agents 
188 
disease_progression 
H-positive risk:  671 691 96 1108 432 92 1125 385 126 64 149 61 
H-negative risk:  691 671 1125 1108 385 432 92 96 149 126 61 64 
New BC onsets:  113
BC status:  4887 113 
BC subtype:  4887 88 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
189 
disease_progression 
H-positive risk:  676 683 96 1111 423 96 1124 393 125 65 149 59 
H-negative risk:  683 676 1124 1111 393 423 96 96 149 125 59 65 
New BC onsets:  114
BC status:  4886 114 
BC subtype:  4886 90 24 

clinical_engagement 
diagnosis 
demography 
72 new agents 
190 
disease_progression 
H-positive risk:  673 690 94 1113 421 99 1113 398 126 64 149 60 
H-negative risk:  690 673 1113 1113 398 421 99 94 149 126 60 64 
New BC onsets:  112
BC status:  4888 112 
BC subtype:  4888 90 22 

clinical_engagement 
diagnosis 
demography 
61 new agents 
191 
disease_progression 
H-positive risk:  663 688 96 1121 417 100 1113 402 126 60 151 63 
H-negative risk:  688 663 1113 1121 402 417 100 96 151 126 63 60 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
91 new agents 
192 
disease_progression 
H-positive risk:  670 684 95 1117 414 100 1116 406 130 54 153 61 
H-negative risk:  684 670 1116 1117 406 414 100 95 153 130 61 54 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 88 21 

clinical_engagement 
diagnosis 
demography 
75 new agents 
193 
disease_progression 
H-positive risk:  671 682 96 1119 412 98 1126 401 133 52 152 58 
H-negative risk:  682 671 1126 1119 401 412 98 96 152 133 58 52 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 87 21 

clinical_engagement 
diagnosis 
demography 
79 new agents 
194 
disease_progression 
H-positive risk:  660 681 99 1116 409 99 1123 419 134 50 154 56 
H-negative risk:  681 660 1123 1116 419 409 99 99 154 134 56 50 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 87 20 

clinical_engagement 
diagnosis 
demography 
87 new agents 
195 
disease_progression 
H-positive risk:  665 680 101 1115 406 101 1125 416 136 49 151 55 
H-negative risk:  680 665 1125 1115 416 406 101 101 151 136 55 49 
New BC onsets:  108
BC status:  4892 108 
BC subtype:  4892 84 24 

clinical_engagement 
diagnosis 
demography 
68 new agents 
196 
disease_progression 
H-positive risk:  659 683 102 1122 401 101 1121 418 136 50 154 53 
H-negative risk:  683 659 1121 1122 418 401 101 102 154 136 53 50 
New BC onsets:  109
BC status:  4891 109 
BC subtype:  4891 84 25 

clinical_engagement 
diagnosis 
demography 
70 new agents 
197 
disease_progression 
H-positive risk:  659 680 100 1124 400 103 1123 421 133 49 156 52 
H-negative risk:  680 659 1123 1124 421 400 103 100 156 133 52 49 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
57 new agents 
198 
disease_progression 
H-positive risk:  647 691 102 1121 397 102 1134 420 133 47 156 50 
H-negative risk:  691 647 1134 1121 420 397 102 102 156 133 50 47 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 81 25 

clinical_engagement 
diagnosis 
demography 
78 new agents 
199 
disease_progression 
H-positive risk:  645 684 104 1130 395 105 1133 423 132 46 156 47 
H-negative risk:  684 645 1133 1130 423 395 105 104 156 132 47 46 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
77 new agents 
200 
disease_progression 
H-positive risk:  647 689 105 1128 391 102 1125 425 136 47 157 48 
H-negative risk:  689 647 1125 1128 425 391 102 105 157 136 48 47 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
78 new agents 
201 
disease_progression 
H-positive risk:  650 694 104 1128 389 101 1131 416 136 47 156 48 
H-negative risk:  694 650 1131 1128 416 389 101 104 156 136 48 47 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 80 22 

clinical_engagement 
diagnosis 
demography 
83 new agents 
202 
disease_progression 
H-positive risk:  653 691 103 1123 393 96 1126 414 145 48 159 49 
H-negative risk:  691 653 1126 1123 414 393 96 103 159 145 49 48 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
54 new agents 
203 
disease_progression 
H-positive risk:  653 688 100 1118 396 97 1129 411 147 53 159 49 
H-negative risk:  688 653 1129 1118 411 396 97 100 159 147 49 53 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
82 new agents 
204 
disease_progression 
H-positive risk:  650 684 101 1117 401 94 1125 416 144 58 158 52 
H-negative risk:  684 650 1125 1117 416 401 94 101 158 144 52 58 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
78 new agents 
205 
disease_progression 
H-positive risk:  659 685 103 1114 401 97 1128 408 139 60 157 49 
H-negative risk:  685 659 1128 1114 408 401 97 103 157 139 49 60 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
206 
disease_progression 
H-positive risk:  661 683 103 1122 404 95 1115 410 143 60 155 49 
H-negative risk:  683 661 1115 1122 410 404 95 103 155 143 49 60 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
207 
disease_progression 
H-positive risk:  663 669 106 1127 409 94 1116 406 145 62 154 49 
H-negative risk:  669 663 1116 1127 406 409 94 106 154 145 49 62 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
208 
disease_progression 
H-positive risk:  663 676 106 1124 414 92 1112 408 144 60 152 49 
H-negative risk:  676 663 1112 1124 408 414 92 106 152 144 49 60 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
209 
disease_progression 
H-positive risk:  664 676 108 1123 416 93 1102 406 148 61 154 49 
H-negative risk:  676 664 1102 1123 406 416 93 108 154 148 49 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
64 new agents 
210 
disease_progression 
H-positive risk:  663 680 112 1116 426 91 1100 405 144 63 153 47 
H-negative risk:  680 663 1100 1116 405 426 91 112 153 144 47 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 81 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
211 
disease_progression 
H-positive risk:  661 684 114 1115 427 91 1085 415 148 61 152 47 
H-negative risk:  684 661 1085 1115 415 427 91 114 152 148 47 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
88 new agents 
212 
disease_progression 
H-positive risk:  674 681 113 1113 427 94 1073 419 148 59 153 46 
H-negative risk:  681 674 1073 1113 419 427 94 113 153 148 46 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 82 19 

clinical_engagement 
diagnosis 
demography 
81 new agents 
213 
disease_progression 
H-positive risk:  672 683 116 1098 432 91 1086 414 148 61 154 45 
H-negative risk:  683 672 1086 1098 414 432 91 116 154 148 45 61 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 78 19 

clinical_engagement 
diagnosis 
demography 
63 new agents 
214 
disease_progression 
H-positive risk:  673 685 117 1101 430 89 1084 423 144 62 150 42 
H-negative risk:  685 673 1084 1101 423 430 89 117 150 144 42 62 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 75 19 

clinical_engagement 
diagnosis 
demography 
76 new agents 
215 
disease_progression 
H-positive risk:  673 683 117 1099 428 91 1080 429 146 63 149 42 
H-negative risk:  683 673 1080 1099 429 428 91 117 149 146 42 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 73 20 

clinical_engagement 
diagnosis 
demography 
65 new agents 
216 
disease_progression 
H-positive risk:  673 686 117 1103 423 91 1078 433 144 63 150 39 
H-negative risk:  686 673 1078 1103 433 423 91 117 150 144 39 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
87 new agents 
217 
disease_progression 
H-positive risk:  668 695 117 1092 437 87 1068 438 143 66 149 40 
H-negative risk:  695 668 1068 1092 438 437 87 117 149 143 40 66 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 74 19 

clinical_engagement 
diagnosis 
demography 
95 new agents 
218 
disease_progression 
H-positive risk:  673 694 115 1093 428 83 1075 437 143 65 152 42 
H-negative risk:  694 673 1075 1093 437 428 83 115 152 143 42 65 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
94 new agents 
219 
disease_progression 
H-positive risk:  679 693 111 1097 420 83 1081 432 143 65 152 44 
H-negative risk:  693 679 1081 1097 432 420 83 111 152 143 44 65 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
84 new agents 
220 
disease_progression 
H-positive risk:  680 691 109 1093 424 80 1086 435 142 68 150 42 
H-negative risk:  691 680 1086 1093 435 424 80 109 150 142 42 68 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 80 18 

clinical_engagement 
diagnosis 
demography 
81 new agents 
221 
disease_progression 
H-positive risk:  676 684 107 1090 428 85 1095 432 140 68 151 44 
H-negative risk:  684 676 1095 1090 432 428 85 107 151 140 44 68 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 80 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
222 
disease_progression 
H-positive risk:  674 688 110 1083 427 85 1097 433 141 65 153 44 
H-negative risk:  688 674 1097 1083 433 427 85 110 153 141 44 65 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
73 new agents 
223 
disease_progression 
H-positive risk:  670 683 110 1085 427 87 1101 433 143 63 152 46 
H-negative risk:  683 670 1101 1085 433 427 87 110 152 143 46 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
73 new agents 
224 
disease_progression 
H-positive risk:  671 685 108 1081 417 88 1104 438 146 61 153 48 
H-negative risk:  685 671 1104 1081 438 417 88 108 153 146 48 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
74 new agents 
225 
disease_progression 
H-positive risk:  668 693 106 1074 414 92 1110 434 144 64 152 49 
H-negative risk:  693 668 1110 1074 434 414 92 106 152 144 49 64 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 80 17 

clinical_engagement 
diagnosis 
demography 
83 new agents 
226 
disease_progression 
H-positive risk:  670 689 108 1079 407 90 1113 435 143 66 152 48 
H-negative risk:  689 670 1113 1079 435 407 90 108 152 143 48 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
71 new agents 
227 
disease_progression 
H-positive risk:  676 693 108 1075 404 91 1114 433 142 65 151 48 
H-negative risk:  693 676 1114 1075 433 404 91 108 151 142 48 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
228 
disease_progression 
H-positive risk:  678 694 108 1076 392 94 1107 439 145 64 156 47 
H-negative risk:  694 678 1107 1076 439 392 94 108 156 145 47 64 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
78 new agents 
229 
disease_progression 
H-positive risk:  684 699 107 1064 398 95 1101 443 145 64 156 44 
H-negative risk:  699 684 1101 1064 443 398 95 107 156 145 44 64 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
97 new agents 
230 
disease_progression 
H-positive risk:  682 708 111 1064 388 95 1101 442 145 63 155 46 
H-negative risk:  708 682 1101 1064 442 388 95 111 155 145 46 63 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
231 
disease_progression 
H-positive risk:  686 708 109 1064 389 93 1095 450 146 63 152 45 
H-negative risk:  708 686 1095 1064 450 389 93 109 152 146 45 63 
New BC onsets:  88
BC status:  4912 88 
BC subtype:  4912 72 16 

clinical_engagement 
diagnosis 
demography 
72 new agents 
232 
disease_progression 
H-positive risk:  682 709 107 1068 391 97 1102 441 143 65 150 45 
H-negative risk:  709 682 1102 1068 441 391 97 107 150 143 45 65 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
233 
disease_progression 
H-positive risk:  685 709 105 1074 381 94 1105 441 147 66 147 46 
H-negative risk:  709 685 1105 1074 441 381 94 105 147 147 46 66 
New BC onsets:  85
BC status:  4915 85 
BC subtype:  4915 70 15 

clinical_engagement 
diagnosis 
demography 
73 new agents 
234 
disease_progression 
H-positive risk:  688 709 103 1076 383 95 1101 441 145 66 150 43 
H-negative risk:  709 688 1101 1076 441 383 95 103 150 145 43 66 
New BC onsets:  87
BC status:  4913 87 
BC subtype:  4913 72 15 

clinical_engagement 
diagnosis 
demography 
81 new agents 
235 
disease_progression 
H-positive risk:  685 710 101 1072 382 94 1108 439 149 67 149 44 
H-negative risk:  710 685 1108 1072 439 382 94 101 149 149 44 67 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 76 14 

clinical_engagement 
diagnosis 
demography 
69 new agents 
236 
disease_progression 
H-positive risk:  684 707 100 1070 385 95 1111 439 151 66 147 45 
H-negative risk:  707 684 1111 1070 439 385 95 100 147 151 45 66 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 76 13 

clinical_engagement 
diagnosis 
demography 
77 new agents 
237 
disease_progression 
H-positive risk:  680 704 100 1071 385 97 1119 441 150 61 146 46 
H-negative risk:  704 680 1119 1071 441 385 97 100 146 150 46 61 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
238 
disease_progression 
H-positive risk:  668 707 98 1071 386 97 1126 442 150 64 145 46 
H-negative risk:  707 668 1126 1071 442 386 97 98 145 150 46 64 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
85 new agents 
239 
disease_progression 
H-positive risk:  667 711 96 1067 385 94 1127 446 152 64 148 43 
H-negative risk:  711 667 1127 1067 446 385 94 96 148 152 43 64 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
65 new agents 
240 
disease_progression 
H-positive risk:  671 710 94 1063 391 95 1123 445 148 66 148 46 
H-negative risk:  710 671 1123 1063 445 391 95 94 148 148 46 66 
New BC onsets:  91
BC status:  4909 91 
BC subtype:  4909 76 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
241 
disease_progression 
H-positive risk:  670 708 92 1059 390 96 1117 456 147 69 146 50 
H-negative risk:  708 670 1117 1059 456 390 96 92 146 147 50 69 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
70 new agents 
242 
disease_progression 
H-positive risk:  678 703 92 1063 390 98 1111 452 148 68 146 51 
H-negative risk:  703 678 1111 1063 452 390 98 92 146 148 51 68 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
97 new agents 
243 
disease_progression 
H-positive risk:  679 705 95 1064 396 95 1110 444 151 66 145 50 
H-negative risk:  705 679 1110 1064 444 396 95 95 145 151 50 66 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 77 18 

clinical_engagement 
diagnosis 
demography 
80 new agents 
244 
disease_progression 
H-positive risk:  684 704 97 1058 400 95 1106 443 151 67 145 50 
H-negative risk:  704 684 1106 1058 443 400 95 97 145 151 50 67 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 78 18 

clinical_engagement 
diagnosis 
demography 
77 new agents 
245 
disease_progression 
H-positive risk:  684 700 98 1062 398 94 1105 447 151 65 144 52 
H-negative risk:  700 684 1105 1062 447 398 94 98 144 151 52 65 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
75 new agents 
246 
disease_progression 
H-positive risk:  680 697 98 1072 404 94 1096 449 152 67 138 53 
H-negative risk:  697 680 1096 1072 449 404 94 98 138 152 53 67 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 76 17 

clinical_engagement 
diagnosis 
demography 
84 new agents 
247 
disease_progression 
H-positive risk:  682 694 99 1071 402 95 1101 449 149 67 136 55 
H-negative risk:  694 682 1101 1071 449 402 95 99 136 149 55 67 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 76 19 

clinical_engagement 
diagnosis 
demography 
74 new agents 
248 
disease_progression 
H-positive risk:  690 693 98 1071 403 97 1099 438 152 66 137 56 
H-negative risk:  693 690 1099 1071 438 403 97 98 137 152 56 66 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
70 new agents 
249 
disease_progression 
H-positive risk:  682 694 101 1070 412 95 1093 444 153 65 134 57 
H-negative risk:  694 682 1093 1070 444 412 95 101 134 153 57 65 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 79 21 

clinical_engagement 
diagnosis 
demography 
77 new agents 
250 
disease_progression 
H-positive risk:  691 685 101 1079 415 94 1091 438 151 67 132 56 
H-negative risk:  685 691 1091 1079 438 415 94 101 132 151 56 67 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
251 
disease_progression 
H-positive risk:  688 687 101 1080 416 96 1089 437 148 68 134 56 
H-negative risk:  687 688 1089 1080 437 416 96 101 134 148 56 68 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 83 21 

clinical_engagement 
diagnosis 
demography 
81 new agents 
252 
disease_progression 
H-positive risk:  693 689 99 1077 412 97 1084 441 152 66 134 56 
H-negative risk:  689 693 1084 1077 441 412 97 99 134 152 56 66 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 85 20 

clinical_engagement 
diagnosis 
demography 
81 new agents 
253 
disease_progression 
H-positive risk:  693 692 101 1078 411 98 1077 440 152 65 135 58 
H-negative risk:  692 693 1077 1078 440 411 98 101 135 152 58 65 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 82 21 

clinical_engagement 
diagnosis 
demography 
85 new agents 
254 
disease_progression 
H-positive risk:  698 689 102 1092 408 99 1073 429 151 68 135 56 
H-negative risk:  689 698 1073 1092 429 408 99 102 135 151 56 68 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 82 20 

clinical_engagement 
diagnosis 
demography 
67 new agents 
255 
disease_progression 
H-positive risk:  697 690 100 1093 408 97 1079 433 151 62 135 55 
H-negative risk:  690 697 1079 1093 433 408 97 100 135 151 55 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 81 20 

clinical_engagement 
diagnosis 
demography 
70 new agents 
256 
disease_progression 
H-positive risk:  704 688 102 1093 407 98 1076 427 149 64 133 59 
H-negative risk:  688 704 1076 1093 427 407 98 102 133 149 59 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 79 19 

clinical_engagement 
diagnosis 
demography 
79 new agents 
257 
disease_progression 
H-positive risk:  703 689 103 1097 403 99 1075 426 150 62 133 60 
H-negative risk:  689 703 1075 1097 426 403 99 103 133 150 60 62 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 77 19 

clinical_engagement 
diagnosis 
demography 
77 new agents 
258 
disease_progression 
H-positive risk:  704 689 101 1094 391 100 1086 433 148 61 131 62 
H-negative risk:  689 704 1086 1094 433 391 100 101 131 148 62 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 76 20 

clinical_engagement 
diagnosis 
demography 
84 new agents 
259 
disease_progression 
H-positive risk:  713 685 101 1101 390 99 1067 440 150 60 132 62 
H-negative risk:  685 713 1067 1101 440 390 99 101 132 150 62 60 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 74 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
260 
disease_progression 
H-positive risk:  713 689 103 1101 387 98 1056 446 152 61 131 63 
H-negative risk:  689 713 1056 1101 446 387 98 103 131 152 63 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
76 new agents 
261 
disease_progression 
H-positive risk:  705 690 104 1106 389 99 1055 444 149 62 133 64 
H-negative risk:  690 705 1055 1106 444 389 99 104 133 149 64 62 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
75 new agents 
262 
disease_progression 
H-positive risk:  695 692 102 1111 392 100 1063 446 144 61 133 61 
H-negative risk:  692 695 1063 1111 446 392 100 102 133 144 61 61 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 76 23 

clinical_engagement 
diagnosis 
demography 
76 new agents 
263 
disease_progression 
H-positive risk:  697 689 102 1111 394 99 1063 443 147 62 133 60 
H-negative risk:  689 697 1063 1111 443 394 99 102 133 147 60 62 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
264 
disease_progression 
H-positive risk:  696 689 104 1126 394 101 1061 430 146 60 133 60 
H-negative risk:  689 696 1061 1126 430 394 101 104 133 146 60 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 75 27 

clinical_engagement 
diagnosis 
demography 
82 new agents 
265 
disease_progression 
H-positive risk:  699 691 105 1127 404 100 1060 419 146 59 132 58 
H-negative risk:  691 699 1060 1127 419 404 100 105 132 146 58 59 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 78 27 

clinical_engagement 
diagnosis 
demography 
71 new agents 
266 
disease_progression 
H-positive risk:  700 693 106 1127 406 99 1056 414 147 60 130 62 
H-negative risk:  693 700 1056 1127 414 406 99 106 130 147 62 60 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 76 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
267 
disease_progression 
H-positive risk:  693 695 107 1127 415 98 1053 414 146 59 129 64 
H-negative risk:  695 693 1053 1127 414 415 98 107 129 146 64 59 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
72 new agents 
268 
disease_progression 
H-positive risk:  690 701 105 1104 424 99 1056 420 149 58 132 62 
H-negative risk:  701 690 1056 1104 420 424 99 105 132 149 62 58 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
83 new agents 
269 
disease_progression 
H-positive risk:  693 701 107 1107 417 97 1063 414 152 56 131 62 
H-negative risk:  701 693 1063 1107 414 417 97 107 131 152 62 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 79 26 

clinical_engagement 
diagnosis 
demography 
67 new agents 
270 
disease_progression 
H-positive risk:  695 695 108 1108 424 97 1060 415 151 54 132 61 
H-negative risk:  695 695 1060 1108 415 424 97 108 132 151 61 54 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
86 new agents 
271 
disease_progression 
H-positive risk:  692 703 108 1107 423 97 1068 405 149 58 133 57 
H-negative risk:  703 692 1068 1107 405 423 97 108 133 149 57 58 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
72 new agents 
272 
disease_progression 
H-positive risk:  687 707 106 1105 428 96 1063 406 149 59 134 60 
H-negative risk:  707 687 1063 1105 406 428 96 106 134 149 60 59 
New BC onsets:  107
BC status:  4893 107 
BC subtype:  4893 78 29 

clinical_engagement 
diagnosis 
demography 
91 new agents 
273 
disease_progression 
H-positive risk:  687 699 110 1112 421 98 1049 422 146 59 135 62 
H-negative risk:  699 687 1049 1112 422 421 98 110 135 146 62 59 
New BC onsets:  106
BC status:  4894 106 
BC subtype:  4894 77 29 

clinical_engagement 
diagnosis 
demography 
95 new agents 
274 
disease_progression 
H-positive risk:  689 690 112 1103 421 99 1057 420 150 59 137 63 
H-negative risk:  690 689 1057 1103 420 421 99 112 137 150 63 59 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
79 new agents 
275 
disease_progression 
H-positive risk:  680 685 110 1100 417 104 1070 425 152 56 136 65 
H-negative risk:  685 680 1070 1100 425 417 104 110 136 152 65 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
276 
disease_progression 
H-positive risk:  686 683 111 1104 415 105 1062 425 153 55 135 66 
H-negative risk:  683 686 1062 1104 425 415 105 111 135 153 66 55 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 76 28 

clinical_engagement 
diagnosis 
demography 
66 new agents 
277 
disease_progression 
H-positive risk:  681 685 110 1108 409 103 1067 420 159 56 137 65 
H-negative risk:  685 681 1067 1108 420 409 103 110 137 159 65 56 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 77 28 

clinical_engagement 
diagnosis 
demography 
78 new agents 
278 
disease_progression 
H-positive risk:  679 685 111 1107 413 102 1059 426 158 57 140 63 
H-negative risk:  685 679 1059 1107 426 413 102 111 140 158 63 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 73 29 

clinical_engagement 
diagnosis 
demography 
70 new agents 
279 
disease_progression 
H-positive risk:  677 687 111 1105 419 103 1056 428 157 57 140 60 
H-negative risk:  687 677 1056 1105 428 419 103 111 140 157 60 57 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 73 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
280 
disease_progression 
H-positive risk:  673 689 112 1106 423 105 1050 423 158 56 144 61 
H-negative risk:  689 673 1050 1106 423 423 105 112 144 158 61 56 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 72 32 

clinical_engagement 
diagnosis 
demography 
71 new agents 
281 
disease_progression 
H-positive risk:  678 692 113 1108 418 103 1052 415 157 57 145 62 
H-negative risk:  692 678 1052 1108 415 418 103 113 145 157 62 57 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 70 34 

clinical_engagement 
diagnosis 
demography 
80 new agents 
282 
disease_progression 
H-positive risk:  680 693 114 1108 421 104 1043 417 155 58 144 63 
H-negative risk:  693 680 1043 1108 417 421 104 114 144 155 63 58 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 69 34 

clinical_engagement 
diagnosis 
demography 
68 new agents 
283 
disease_progression 
H-positive risk:  684 696 116 1108 416 104 1047 412 153 60 139 65 
H-negative risk:  696 684 1047 1108 412 416 104 116 139 153 65 60 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 71 34 

clinical_engagement 
diagnosis 
demography 
66 new agents 
284 
disease_progression 
H-positive risk:  687 700 115 1109 419 100 1044 409 154 59 140 64 
H-negative risk:  700 687 1044 1109 409 419 100 115 140 154 64 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 70 32 

clinical_engagement 
diagnosis 
demography 
80 new agents 
285 
disease_progression 
H-positive risk:  686 701 115 1107 422 99 1044 409 153 59 140 65 
H-negative risk:  701 686 1044 1107 409 422 99 115 140 153 65 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
79 new agents 
286 
disease_progression 
H-positive risk:  689 703 113 1104 422 99 1047 407 155 57 140 64 
H-negative risk:  703 689 1047 1104 407 422 99 113 140 155 64 57 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 71 31 

clinical_engagement 
diagnosis 
demography 
87 new agents 
287 
disease_progression 
H-positive risk:  696 696 111 1102 423 100 1046 401 153 61 145 66 
H-negative risk:  696 696 1046 1102 401 423 100 111 145 153 66 61 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 70 30 

clinical_engagement 
diagnosis 
demography 
79 new agents 
288 
disease_progression 
H-positive risk:  697 695 110 1096 427 100 1054 394 152 61 148 66 
H-negative risk:  695 697 1054 1096 394 427 100 110 148 152 66 61 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 73 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
289 
disease_progression 
H-positive risk:  690 695 112 1099 431 97 1053 394 150 62 151 66 
H-negative risk:  695 690 1053 1099 394 431 97 112 151 150 66 62 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 73 30 

clinical_engagement 
diagnosis 
demography 
77 new agents 
290 
disease_progression 
H-positive risk:  688 695 109 1112 426 95 1044 397 154 63 153 64 
H-negative risk:  695 688 1044 1112 397 426 95 109 153 154 64 63 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 75 30 

clinical_engagement 
diagnosis 
demography 
82 new agents 
291 
disease_progression 
H-positive risk:  689 697 106 1114 420 97 1051 400 147 64 156 59 
H-negative risk:  697 689 1051 1114 400 420 97 106 156 147 59 64 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
71 new agents 
292 
disease_progression 
H-positive risk:  698 692 108 1114 422 97 1046 404 148 59 156 56 
H-negative risk:  692 698 1046 1114 404 422 97 108 156 148 56 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 70 28 

clinical_engagement 
diagnosis 
demography 
73 new agents 
293 
disease_progression 
H-positive risk:  695 696 106 1124 418 98 1045 402 149 59 153 55 
H-negative risk:  696 695 1045 1124 402 418 98 106 153 149 55 59 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
97 new agents 
294 
disease_progression 
H-positive risk:  695 697 103 1128 415 102 1041 401 149 57 155 57 
H-negative risk:  697 695 1041 1128 401 415 102 103 155 149 57 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 65 28 

clinical_engagement 
diagnosis 
demography 
80 new agents 
295 
disease_progression 
H-positive risk:  685 701 102 1130 412 103 1050 401 149 57 153 57 
H-negative risk:  701 685 1050 1130 401 412 103 102 153 149 57 57 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 66 26 

clinical_engagement 
diagnosis 
demography 
65 new agents 
296 
disease_progression 
H-positive risk:  688 696 102 1133 408 101 1056 401 149 54 151 61 
H-negative risk:  696 688 1056 1133 401 408 101 102 151 149 61 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 68 26 

clinical_engagement 
diagnosis 
demography 
72 new agents 
297 
disease_progression 
H-positive risk:  686 694 102 1131 413 102 1046 411 150 53 152 60 
H-negative risk:  694 686 1046 1131 411 413 102 102 152 150 60 53 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 68 25 

clinical_engagement 
diagnosis 
demography 
66 new agents 
298 
disease_progression 
H-positive risk:  695 697 104 1121 411 103 1042 413 147 55 153 59 
H-negative risk:  697 695 1042 1121 413 411 103 104 153 147 59 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
75 new agents 
299 
disease_progression 
H-positive risk:  692 702 102 1120 406 100 1042 421 150 54 153 58 
H-negative risk:  702 692 1042 1120 421 406 100 102 153 150 58 54 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
73 new agents 
300 
disease_progression 
H-positive risk:  694 707 102 1117 403 103 1040 422 154 50 149 59 
H-negative risk:  707 694 1040 1117 422 403 103 102 149 154 59 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 71 27 

clinical_engagement 
diagnosis 
demography 
73 new agents 
301 
disease_progression 
H-positive risk:  686 709 101 1113 402 104 1054 419 151 50 151 60 
H-negative risk:  709 686 1054 1113 419 402 104 101 151 151 60 50 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 69 27 

clinical_engagement 
diagnosis 
demography 
103 new agents 
302 
disease_progression 
H-positive risk:  691 711 99 1112 400 103 1060 408 151 51 155 59 
H-negative risk:  711 691 1060 1112 408 400 103 99 155 151 59 51 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 69 26 

clinical_engagement 
diagnosis 
demography 
73 new agents 
303 
disease_progression 
H-positive risk:  686 707 101 1102 403 105 1071 407 150 51 154 63 
H-negative risk:  707 686 1071 1102 407 403 105 101 154 150 63 51 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 70 26 

clinical_engagement 
diagnosis 
demography 
84 new agents 
304 
disease_progression 
H-positive risk:  687 702 103 1111 399 106 1067 408 152 49 153 63 
H-negative risk:  702 687 1067 1111 408 399 106 103 153 152 63 49 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 70 25 

clinical_engagement 
diagnosis 
demography 
81 new agents 
305 
disease_progression 
H-positive risk:  685 703 106 1110 399 106 1064 414 154 47 151 61 
H-negative risk:  703 685 1064 1110 414 399 106 106 151 154 61 47 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 72 25 

clinical_engagement 
diagnosis 
demography 
73 new agents 
306 
disease_progression 
H-positive risk:  689 702 103 1109 398 105 1064 420 151 50 151 58 
H-negative risk:  702 689 1064 1109 420 398 105 103 151 151 58 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
84 new agents 
307 
disease_progression 
H-positive risk:  694 702 104 1100 403 104 1063 424 149 49 152 56 
H-negative risk:  702 694 1063 1100 424 403 104 104 152 149 56 49 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
82 new agents 
308 
disease_progression 
H-positive risk:  688 700 103 1104 401 103 1064 429 146 50 154 58 
H-negative risk:  700 688 1064 1104 429 401 103 103 154 146 58 50 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 77 24 

clinical_engagement 
diagnosis 
demography 
65 new agents 
309 
disease_progression 
H-positive risk:  691 697 99 1107 400 105 1065 423 149 49 155 60 
H-negative risk:  697 691 1065 1107 423 400 105 99 155 149 60 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 78 24 

clinical_engagement 
diagnosis 
demography 
71 new agents 
310 
disease_progression 
H-positive risk:  694 690 98 1120 396 105 1059 425 151 47 154 61 
H-negative risk:  690 694 1059 1120 425 396 105 98 154 151 61 47 
New BC onsets:  104
BC status:  4896 104 
BC subtype:  4896 81 23 

clinical_engagement 
diagnosis 
demography 
87 new agents 
311 
disease_progression 
H-positive risk:  696 692 98 1116 390 105 1054 432 149 49 158 61 
H-negative risk:  692 696 1054 1116 432 390 105 98 158 149 61 49 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
69 new agents 
312 
disease_progression 
H-positive risk:  692 690 99 1113 395 98 1057 432 155 51 159 59 
H-negative risk:  690 692 1057 1113 432 395 98 99 159 155 59 51 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
72 new agents 
313 
disease_progression 
H-positive risk:  690 684 99 1112 406 99 1058 432 153 50 158 59 
H-negative risk:  684 690 1058 1112 432 406 99 99 158 153 59 50 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 75 24 

clinical_engagement 
diagnosis 
demography 
69 new agents 
314 
disease_progression 
H-positive risk:  687 684 96 1107 414 97 1065 426 153 52 160 59 
H-negative risk:  684 687 1065 1107 426 414 97 96 160 153 59 52 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
83 new agents 
315 
disease_progression 
H-positive risk:  683 682 99 1109 409 99 1077 418 155 51 160 58 
H-negative risk:  682 683 1077 1109 418 409 99 99 160 155 58 51 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 79 23 

clinical_engagement 
diagnosis 
demography 
88 new agents 
316 
disease_progression 
H-positive risk:  685 671 101 1120 415 96 1075 418 157 48 159 55 
H-negative risk:  671 685 1075 1120 418 415 96 101 159 157 55 48 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 78 23 

clinical_engagement 
diagnosis 
demography 
68 new agents 
317 
disease_progression 
H-positive risk:  679 680 103 1122 414 96 1068 422 152 51 158 55 
H-negative risk:  680 679 1068 1122 422 414 96 103 158 152 55 51 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 79 22 

clinical_engagement 
diagnosis 
demography 
96 new agents 
318 
disease_progression 
H-positive risk:  676 681 102 1124 410 93 1073 425 153 47 164 52 
H-negative risk:  681 676 1073 1124 425 410 93 102 164 153 52 47 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 77 23 

clinical_engagement 
diagnosis 
demography 
85 new agents 
319 
disease_progression 
H-positive risk:  675 685 101 1116 408 91 1071 430 153 48 170 52 
H-negative risk:  685 675 1071 1116 430 408 91 101 170 153 52 48 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 77 22 

clinical_engagement 
diagnosis 
demography 
75 new agents 
320 
disease_progression 
H-positive risk:  671 683 105 1115 410 93 1074 423 150 49 174 53 
H-negative risk:  683 671 1074 1115 423 410 93 105 174 150 53 49 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 76 22 

clinical_engagement 
diagnosis 
demography 
69 new agents 
321 
disease_progression 
H-positive risk:  669 679 104 1118 411 93 1070 425 150 50 175 56 
H-negative risk:  679 669 1070 1118 425 411 93 104 175 150 56 50 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 78 20 

clinical_engagement 
diagnosis 
demography 
69 new agents 
322 
disease_progression 
H-positive risk:  664 682 104 1113 413 90 1071 428 148 54 177 56 
H-negative risk:  682 664 1071 1113 428 413 90 104 177 148 56 54 
New BC onsets:  99
BC status:  4901 99 
BC subtype:  4901 79 20 

clinical_engagement 
diagnosis 
demography 
83 new agents 
323 
disease_progression 
H-positive risk:  664 689 103 1109 410 92 1071 425 148 56 179 54 
H-negative risk:  689 664 1071 1109 425 410 92 103 179 148 54 56 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 79 18 

clinical_engagement 
diagnosis 
demography 
79 new agents 
324 
disease_progression 
H-positive risk:  660 689 104 1109 406 91 1078 420 148 56 184 55 
H-negative risk:  689 660 1078 1109 420 406 91 104 184 148 55 56 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
92 new agents 
325 
disease_progression 
H-positive risk:  651 697 103 1120 398 93 1074 423 147 54 184 56 
H-negative risk:  697 651 1074 1120 423 398 93 103 184 147 56 54 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
76 new agents 
326 
disease_progression 
H-positive risk:  654 700 102 1113 409 93 1078 414 146 52 185 54 
H-negative risk:  700 654 1078 1113 414 409 93 102 185 146 54 52 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
88 new agents 
327 
disease_progression 
H-positive risk:  665 697 102 1106 408 91 1083 411 150 50 181 56 
H-negative risk:  697 665 1083 1106 411 408 91 102 181 150 56 50 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 79 14 

clinical_engagement 
diagnosis 
demography 
72 new agents 
328 
disease_progression 
H-positive risk:  669 700 102 1104 406 93 1083 405 152 52 179 55 
H-negative risk:  700 669 1083 1104 405 406 93 102 179 152 55 52 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 74 16 

clinical_engagement 
diagnosis 
demography 
67 new agents 
329 
disease_progression 
H-positive risk:  668 694 104 1105 408 93 1084 409 153 52 178 52 
H-negative risk:  694 668 1084 1105 409 408 93 104 178 153 52 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 73 16 

clinical_engagement 
diagnosis 
demography 
66 new agents 
330 
disease_progression 
H-positive risk:  666 698 105 1106 408 92 1079 409 153 52 178 54 
H-negative risk:  698 666 1079 1106 409 408 92 105 178 153 54 52 
New BC onsets:  89
BC status:  4911 89 
BC subtype:  4911 74 15 

clinical_engagement 
diagnosis 
demography 
80 new agents 
331 
disease_progression 
H-positive risk:  662 690 104 1120 402 92 1075 413 155 51 182 54 
H-negative risk:  690 662 1075 1120 413 402 92 104 182 155 54 51 
New BC onsets:  90
BC status:  4910 90 
BC subtype:  4910 75 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
332 
disease_progression 
H-positive risk:  662 694 103 1126 395 89 1077 413 154 52 184 51 
H-negative risk:  694 662 1077 1126 413 395 89 103 184 154 51 52 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
333 
disease_progression 
H-positive risk:  654 697 102 1127 400 89 1077 408 156 51 187 52 
H-negative risk:  697 654 1077 1127 408 400 89 102 187 156 52 51 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
82 new agents 
334 
disease_progression 
H-positive risk:  654 706 101 1128 390 88 1077 411 150 55 189 51 
H-negative risk:  706 654 1077 1128 411 390 88 101 189 150 51 55 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 78 16 

clinical_engagement 
diagnosis 
demography 
74 new agents 
335 
disease_progression 
H-positive risk:  654 712 103 1128 396 86 1063 415 150 55 189 49 
H-negative risk:  712 654 1063 1128 415 396 86 103 189 150 49 55 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
76 new agents 
336 
disease_progression 
H-positive risk:  657 713 102 1117 405 85 1059 414 153 57 190 48 
H-negative risk:  713 657 1059 1117 414 405 85 102 190 153 48 57 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 77 16 

clinical_engagement 
diagnosis 
demography 
87 new agents 
337 
disease_progression 
H-positive risk:  660 712 104 1121 403 82 1063 411 152 56 186 50 
H-negative risk:  712 660 1063 1121 411 403 82 104 186 152 50 56 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 76 16 

clinical_engagement 
diagnosis 
demography 
75 new agents 
338 
disease_progression 
H-positive risk:  655 717 104 1121 399 81 1059 417 153 55 188 51 
H-negative risk:  717 655 1059 1121 417 399 81 104 188 153 51 55 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
81 new agents 
339 
disease_progression 
H-positive risk:  650 722 102 1119 401 83 1064 409 153 57 187 53 
H-negative risk:  722 650 1064 1119 409 401 83 102 187 153 53 57 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
96 new agents 
340 
disease_progression 
H-positive risk:  649 729 107 1115 395 83 1059 413 151 58 187 54 
H-negative risk:  729 649 1059 1115 413 395 83 107 187 151 54 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 79 16 

clinical_engagement 
diagnosis 
demography 
63 new agents 
341 
disease_progression 
H-positive risk:  648 734 110 1112 391 81 1063 413 150 60 183 55 
H-negative risk:  734 648 1063 1112 413 391 81 110 183 150 55 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
342 
disease_progression 
H-positive risk:  647 732 110 1115 386 83 1056 413 156 61 185 56 
H-negative risk:  732 647 1056 1115 413 386 83 110 185 156 56 61 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 81 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
343 
disease_progression 
H-positive risk:  644 719 112 1124 386 84 1059 417 154 63 185 53 
H-negative risk:  719 644 1059 1124 417 386 84 112 185 154 53 63 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
66 new agents 
344 
disease_progression 
H-positive risk:  640 719 112 1125 381 81 1060 429 154 63 181 55 
H-negative risk:  719 640 1060 1125 429 381 81 112 181 154 55 63 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
72 new agents 
345 
disease_progression 
H-positive risk:  644 725 112 1117 377 78 1062 432 157 61 179 56 
H-negative risk:  725 644 1062 1117 432 377 78 112 179 157 56 61 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
97 new agents 
346 
disease_progression 
H-positive risk:  637 733 110 1122 380 78 1060 431 155 60 178 56 
H-negative risk:  733 637 1060 1122 431 380 78 110 178 155 56 60 
New BC onsets:  93
BC status:  4907 93 
BC subtype:  4907 78 15 

clinical_engagement 
diagnosis 
demography 
86 new agents 
347 
disease_progression 
H-positive risk:  637 734 112 1122 386 76 1054 431 157 60 180 51 
H-negative risk:  734 637 1054 1122 431 386 76 112 180 157 51 60 
New BC onsets:  92
BC status:  4908 92 
BC subtype:  4908 77 15 

clinical_engagement 
diagnosis 
demography 
67 new agents 
348 
disease_progression 
H-positive risk:  640 728 109 1119 391 78 1059 427 158 60 177 54 
H-negative risk:  728 640 1059 1119 427 391 78 109 177 158 54 60 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 80 15 

clinical_engagement 
diagnosis 
demography 
77 new agents 
349 
disease_progression 
H-positive risk:  644 733 109 1117 393 79 1049 425 157 64 173 57 
H-negative risk:  733 644 1049 1117 425 393 79 109 173 157 57 64 
New BC onsets:  94
BC status:  4906 94 
BC subtype:  4906 79 15 

clinical_engagement 
diagnosis 
demography 
75 new agents 
350 
disease_progression 
H-positive risk:  649 731 106 1108 399 82 1048 427 158 64 172 56 
H-negative risk:  731 649 1048 1108 427 399 82 106 172 158 56 64 
New BC onsets:  96
BC status:  4904 96 
BC subtype:  4904 79 17 

clinical_engagement 
diagnosis 
demography 
66 new agents 
351 
disease_progression 
H-positive risk:  648 724 108 1113 398 82 1052 429 157 62 170 57 
H-negative risk:  724 648 1052 1113 429 398 82 108 170 157 57 62 
New BC onsets:  97
BC status:  4903 97 
BC subtype:  4903 77 20 

clinical_engagement 
diagnosis 
demography 
72 new agents 
352 
disease_progression 
H-positive risk:  647 722 107 1108 404 82 1053 429 152 63 174 59 
H-negative risk:  722 647 1053 1108 429 404 82 107 174 152 59 63 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 78 22 

clinical_engagement 
diagnosis 
demography 
85 new agents 
353 
disease_progression 
H-positive risk:  647 722 102 1114 397 84 1056 424 155 61 180 58 
H-negative risk:  722 647 1056 1114 424 397 84 102 180 155 58 61 
New BC onsets:  105
BC status:  4895 105 
BC subtype:  4895 82 23 

clinical_engagement 
diagnosis 
demography 
82 new agents 
354 
disease_progression 
H-positive risk:  654 718 104 1116 396 85 1050 420 154 60 181 62 
H-negative risk:  718 654 1050 1116 420 396 85 104 181 154 62 60 
New BC onsets:  103
BC status:  4897 103 
BC subtype:  4897 80 23 

clinical_engagement 
diagnosis 
demography 
77 new agents 
355 
disease_progression 
H-positive risk:  660 720 100 1110 393 84 1057 416 157 59 182 62 
H-negative risk:  720 660 1057 1110 416 393 84 100 182 157 62 59 
New BC onsets:  102
BC status:  4898 102 
BC subtype:  4898 77 25 

clinical_engagement 
diagnosis 
demography 
83 new agents 
356 
disease_progression 
H-positive risk:  663 710 100 1114 397 85 1056 419 158 58 178 62 
H-negative risk:  710 663 1056 1114 419 397 85 100 178 158 62 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 76 25 

clinical_engagement 
diagnosis 
demography 
94 new agents 
357 
disease_progression 
H-positive risk:  664 708 101 1103 408 86 1052 420 158 59 179 62 
H-negative risk:  708 664 1052 1103 420 408 86 101 179 158 62 59 
New BC onsets:  98
BC status:  4902 98 
BC subtype:  4902 73 25 

clinical_engagement 
diagnosis 
demography 
95 new agents 
358 
disease_progression 
H-positive risk:  667 717 101 1093 412 89 1047 417 161 58 178 60 
H-negative risk:  717 667 1047 1093 417 412 89 101 178 161 60 58 
New BC onsets:  95
BC status:  4905 95 
BC subtype:  4905 71 24 

clinical_engagement 
diagnosis 
demography 
88 new agents 
359 
disease_progression 
H-positive risk:  672 715 100 1092 403 92 1052 421 157 58 177 61 
H-negative risk:  715 672 1052 1092 421 403 92 100 177 157 61 58 
New BC onsets:  101
BC status:  4899 101 
BC subtype:  4899 74 27 

clinical_engagement 
diagnosis 
demography 
72 new agents 
360 
disease_progression 
H-positive risk:  668 721 101 1087 394 93 1058 427 151 60 177 63 
H-negative risk:  721 668 1058 1087 427 394 93 101 177 151 63 60 
New BC onsets:  100
BC status:  4900 100 
BC subtype:  4900 73 27 

clinical_engagement 
diagnosis 
demography 
84 new agents 
Time difference of 16.23127 mins
This is task 25
